Publication:
Integration of RNA Editing into Multiomics Machine Learning Models for Predicting Drug Responses in Breast Cancer Patients

Simple item page
dc.contributor.authorBernal, Yanara
dc.contributor.authorBlanco, Alejandro
dc.contributor.authorOróstica, Karen
dc.contributor.authorDelgado, Iris
dc.contributor.authorArmisen, Ricardo
dc.date.accessioned2026-03-27T14:40:36Z
dc.date.available2026-03-27T14:40:36Z
dc.date.issued2026
dc.description.abstractBackground: The integration of multi-omics data, such as genomics and transcriptomics, into artificial intelligence models has advanced precision medicine. However, their clinical applicability remains limited due to model complexity. We integrated DNA mutation, RNA expression, and A>I(G) RNA editing data to develop a predictive model for drug response in breast cancer. Methods: We analyzed 104 patients from the Breast Cancer Genome-Guided Therapy Study (ClinicalTrials.gov: NCT02022202). Clinical variables, gene expression, tumor and germline DNA variants, and RNA editing features were integrated into machine learning models to predict therapy response. Generalized linear models (GLM), random forest (RF), and support vector machines (SVM) were trained and evaluated across multiple random 70/30 train-test splits. Feature selection was performed exclusively within the training set using LASSO regularization. Model performance was assessed using the F1-score on independent test sets. The additive effect of RNA editing was evaluated using paired comparisons across identical train/test splits. Results: We characterized the cohort using clinical, mutational, transcriptomic, and RNA editing profiles in 69 non-responders and 35 responders. Across repeated splits, adding RNA editing frequently maintained or modestly improved predictive performance, particularly in expression-based models, with paired analyses showing a statistically significant increase in F1-score. Conclusions: RNA editing represents a complementary molecular layer that can enhance multi-omic models for therapy response prediction in breast cancer, supporting further investigation of epitranscriptomic features in precision oncology.
dc.description.versionVersión Publicada
dc.identifier.citationBernal, Y. A., Blanco, A., Oróstica, K., Delgado, I., & Armisén, R. (2026). Integration of RNA Editing into Multiomics Machine Learning Models for Predicting Drug Responses in Breast Cancer Patients. Biomedicines, 14(3), 665. https://doi.org/10.3390/biomedicines14030665
dc.identifier.doihttps://doi.org/10.3390/biomedicines14030665
dc.identifier.urihttps://hdl.handle.net/11447/10665
dc.language.isoen
dc.subjectPrecision medicine
dc.subjectMachine learning
dc.subjectMulti-omics
dc.subjectRNA editing
dc.subjectBreast cancer
dc.subjectDrug response
dc.titleIntegration of RNA Editing into Multiomics Machine Learning Models for Predicting Drug Responses in Breast Cancer Patients
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceBiomedicines
dspace.entity.typePublication
relation.isAuthorOfPublication963fc4d8-b9ef-4df5-88be-cd7075c2955f
relation.isAuthorOfPublicationf814e5ac-2623-4a1f-bc2b-5a1a260ee316
relation.isAuthorOfPublication.latestForDiscovery963fc4d8-b9ef-4df5-88be-cd7075c2955f

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Integration of RNA Editing into Multiomics Machine Learning.pdf
Size:
6.78 MB
Format:
Adobe Portable Document Format
Description:
Texto Completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services